1. Home
  2. IMRN vs QMCO Comparison

IMRN vs QMCO Comparison

Compare IMRN & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • QMCO
  • Stock Information
  • Founded
  • IMRN 1994
  • QMCO 1980
  • Country
  • IMRN Australia
  • QMCO United States
  • Employees
  • IMRN N/A
  • QMCO N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • QMCO Electronic Components
  • Sector
  • IMRN Health Care
  • QMCO Technology
  • Exchange
  • IMRN Nasdaq
  • QMCO Nasdaq
  • Market Cap
  • IMRN 9.2M
  • QMCO 61.3M
  • IPO Year
  • IMRN N/A
  • QMCO N/A
  • Fundamental
  • Price
  • IMRN N/A
  • QMCO $9.06
  • Analyst Decision
  • IMRN Strong Buy
  • QMCO Hold
  • Analyst Count
  • IMRN 1
  • QMCO 2
  • Target Price
  • IMRN $5.00
  • QMCO $19.00
  • AVG Volume (30 Days)
  • IMRN 24.6K
  • QMCO 1.7M
  • Earning Date
  • IMRN 07-15-2025
  • QMCO 06-30-2025
  • Dividend Yield
  • IMRN N/A
  • QMCO N/A
  • EPS Growth
  • IMRN N/A
  • QMCO N/A
  • EPS
  • IMRN N/A
  • QMCO N/A
  • Revenue
  • IMRN $4,048,286.00
  • QMCO $285,865,000.00
  • Revenue This Year
  • IMRN N/A
  • QMCO N/A
  • Revenue Next Year
  • IMRN N/A
  • QMCO $2.46
  • P/E Ratio
  • IMRN N/A
  • QMCO N/A
  • Revenue Growth
  • IMRN 82.90
  • QMCO N/A
  • 52 Week Low
  • IMRN $1.50
  • QMCO $2.22
  • 52 Week High
  • IMRN $2.87
  • QMCO $90.64
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 49.46
  • QMCO 43.36
  • Support Level
  • IMRN $1.56
  • QMCO $8.60
  • Resistance Level
  • IMRN $1.96
  • QMCO $10.04
  • Average True Range (ATR)
  • IMRN 0.11
  • QMCO 0.68
  • MACD
  • IMRN -0.01
  • QMCO 0.03
  • Stochastic Oscillator
  • IMRN 53.75
  • QMCO 52.62

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.

Share on Social Networks: